D
Elevance Health, Inc. ELV
$294.18 $6.292.19% NYSE
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
52-Week Range
P/E (TTM)
EPS (TTM)

Company Overview

Elevance Health, Inc. is a U.S.-based health benefits company operating primarily in the managed healthcare and health services industries. The company provides health insurance products, pharmacy benefits, and integrated healthcare services to individuals, employers, government-sponsored programs, and healthcare providers. Its core activities center on administering medical benefits, managing healthcare costs, and supporting care delivery through data-driven and service-based platforms.

The company’s primary revenue drivers include premium-based health benefits, government-sponsored healthcare programs, and fee-based health services. Elevance Health serves commercial customers, Medicare and Medicaid beneficiaries, and employer groups, with a strategic emphasis on value-based care and whole-health solutions. Formerly known as Anthem, Inc., the company was founded in 1944 and evolved through multiple Blue Cross and Blue Shield plan acquisitions. In 2022, it rebranded as Elevance Health to reflect a broader focus beyond traditional insurance toward integrated health services and care delivery.

Business Operations

Elevance Health operates through three primary business segments: Health Benefits, CarelonRx, and Carelon Services. The Health Benefits segment provides medical, dental, vision, and other health insurance products across commercial, Medicare, and Medicaid markets, representing the largest share of company revenue. CarelonRx manages pharmacy benefit services, including prescription drug plans, formulary management, and specialty pharmacy solutions. Carelon Services delivers healthcare-related services such as behavioral health, complex care management, data analytics, and care coordination.

Operations are predominantly domestic, with business conducted across multiple U.S. states under affiliated Blue Cross and Blue Shield licenses, including subsidiaries such as Anthem Blue Cross, Anthem Blue Cross and Blue Shield, and Empire BlueCross BlueShield. The company controls significant healthcare data assets, care management platforms, and pharmacy benefit infrastructure. Elevance Health also maintains strategic relationships with healthcare providers, employers, and government agencies, and operates through wholly owned subsidiaries rather than material joint ventures.

Strategic Position & Investments

Elevance Health’s strategic direction focuses on expanding integrated care capabilities, scaling value-based care models, and increasing penetration in government-sponsored healthcare programs. The company has invested heavily in its Carelon platform to diversify revenue beyond insurance underwriting and to support end-to-end healthcare solutions spanning benefits, care delivery, and pharmacy management. Growth initiatives emphasize affordability, digital health enablement, and improved health outcomes through coordinated care.

Major investments include acquisitions and internal build-outs within behavioral health, specialty care, and data analytics. Notable subsidiaries under the Carelon brand include Carelon Behavioral Health, Carelon Medical Benefits Management, and Carelon Insights. The company is also engaged in emerging healthcare sectors such as home-based care, digital care navigation, and advanced analytics, aligning with its strategy to address social determinants of health and whole-person care.

Geographic Footprint

Elevance Health is headquartered in Indianapolis, Indiana, and operates primarily within the United States. Its health plans and service offerings span a majority of U.S. states, with particularly strong market presence in California, New York, Ohio, Georgia, Virginia, and Indiana. The company’s Blue Cross and Blue Shield-affiliated plans give it broad regional coverage across commercial and government healthcare markets.

International operations are limited and not a core focus of the company’s strategy. However, Elevance Health maintains a modest international footprint through service operations, technology support, and analytics capabilities that support its U.S.-based businesses. Overall, its operational and investment influence remains concentrated in the North American healthcare system.

Leadership & Governance

Elevance Health is led by an experienced executive team with deep backgrounds in healthcare, insurance, and regulated industries. The leadership emphasizes a strategic vision centered on whole-health care, long-term value creation, and aligning financial performance with improved health outcomes. Corporate governance follows public company standards with oversight by an independent board of directors.

Key executives include:

  • Gail K. Boudreaux – President and Chief Executive Officer
  • John Gallina – Executive Vice President and Chief Financial Officer
  • Dr. Shantanu Agrawal – Chief Health Officer
  • Robert L. Dixon – Executive Vice President and Chief Information Officer
  • Andrea L. Jones – Executive Vice President and Chief Human Resources Officer

The leadership team promotes a philosophy focused on innovation, operational discipline, and addressing systemic healthcare challenges through integrated solutions.

Data complied by narrative technology. May contain errors

Top Tech Stocks
See All »
B
NVDA NASDAQ $184.93
B
AAPL NASDAQ $255.70
B
MSFT NASDAQ $401.27
Top Consumer Staple Stocks
See All »
B
WMT NASDAQ $126.01
B
Top Financial Stocks
See All »
B
B
JPM NYSE $286.17
B
V NYSE $309.64
Top Energy Stocks
See All »
B
ENB.TO TSX $73.47
B
ENB NYSE $54.18
Top Health Care Stocks
See All »
B
LLY NYSE $999.79
B
JNJ NYSE $244.39
B
AMGN NASDAQ $370.16
Top Real Estate Stocks
See All »
B
PLD NYSE $133.39